This bill amends the Defense Production Act of 1950 to strengthen the nation's medical supply chains by giving the federal government expanded authority to secure critical pharmaceuticals, medical devices, and biological products deemed essential to national defense. The legislation requires the President to develop a comprehensive strategy within 180 days that identifies vulnerabilities in medical supply chains, recommends ways to diversify sources away from exclusive foreign control, and outlines a timeline for implementation, with annual progress reports due through 2029. The bill also allows the President to make direct payments to U.S. companies that produce critical medical components or materials, provided Congress is notified at least 30 days in advance that such payments are necessary for national defense. The regulations defining "supply chain" and "supply chain activities" must be established within 90 days of enactment. Overall, the legislation aims to reduce American dependence on foreign sources for vital medicines and medical equipment while maintaining U.S. competitiveness and scientific innovation.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.